At Penn Medicine's Abramson Cancer Center, researchers have been the first to apply CRISPR technology to patients (Austinmurphy // CC BY-SA 3.0).
The Daily Pennsylvanian is an independent, student-run newspaper. Please consider making a donation to support the coverage that shapes the University. Your generosity ensures a future of strong journalism at Penn.
Donate
